Cadila Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 1991.

1991 Ahmedabad, Gujarat, India Active

Last Updated: December 09, 2025

About Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Limited, a active public limited company, was established on 28 February 1991 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1991PLC015132. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹120.65 Cr and a paid-up capital of ₹80.01 Cr.

Formerly known as Nova Biotics (India) Pvt Ltd, Nova Biostic (India) Private Limited. It upholds a compliant status. Employing 6,144 professional, Its leadership includes Rajiv Rajiv Modi (Director), Subir Kumar Das (Additional Director), Parul Nikunj Shah (Additional Director). Past directors included Ajit Singh, Rajiv Rajiv Modi, Akhilesh Jain. It holds ₹4,155.28 Cr open charges and ₹3,605.28 Cr settled loans. Its latest AGM occurred on 14 August 2024, with the balance sheet filed on 31 March 2024. It is based at Cadila Corporate Campus Sarkhej Dholka Road,Bhat, Ahmedabad, Gujarat, 382210.

Company Details

CIN/LLPIN
U24231GJ1991PLC015132
Registration Number
015132
Incorporation Date
28 February 1991
Authorized Capital
₹120.65 Cr
Paid-Up Capital
₹80.01 Cr
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 120.65 Cr as on 09-12-2025
Paid Up Capital ₹ 80.01 Cr as on 09-12-2025
Company Age 34 Year, 11 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 4,155.28 Cr as on 09-12-2025
Satisfied Charges ₹ 3,605.28 Cr as on 09-12-2025
Revenue Growth **** -0.45% (FY 2024)
Profit Growth **** 521.68% (FY 2024)
Ebitda **** 112.06% (FY 2024)
Net Worth 17.75% (FY 2024)
Total Assets **** 23.09% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Cadila Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cadila Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rajiv Rajiv Modi	Director	18 Jul 2024	Current
Subir Kumar Das	Additional Director	30 Jun 2025	Current
Parul Nikunj Shah	Additional Director	01 Dec 2023	Current
Rajiv Indravadan Modi	Managing Director	28 Feb 1991	Current
Girdhar Prem Balwani	Director	01 May 2017	Current
Ramesh Ratilal Choksi	Whole-Time Director	07 Feb 2014	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	11 Sep 2017	Past
Pramod Abcsdd	Additional Director	13 Aug 2024	Past
Pramod Abcsdd	Company Secretary	18 Sep 2023	Past
Pramod Abcsdd	Managing Director	26 Nov 2012	Past
Pramod Abcsdd	Director	25 Nov 2021	Past
Pramod Abcsdd	Director	02 Jun 2013	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cadila Pharmaceuticals.

Cadila Pharmaceuticals Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 0.45% decrease. The company also saw a substantial improvement in profitability, with a 521.68% increase in profit. The company's net worth Soared by an impressive increase of 17.75%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-0.45%

*******

Revenue from Operations

*******

0.10%

*******

Total Assets

*******

23.09%

*******

Profit or Loss

*******

521.68%

*******

Net Worth

*******

17.75%

*******

EBITDA

*******

112.06%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cadila Pharmaceuticals?

In 2024, Cadila Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹41,552,820,000.00

Satisfied Charges

₹36,052,840,000.00

Charges Breakdown by Lending Institutions

Others : 3394.85 Cr
Canara Bank : 300.00 Cr
Indian Bank : 260.00 Cr
Bank Of India : 200.00 Cr
Hdfc Bank Limited : 0.43 Cr

Latest Charge Details

Date	Lender	Amount	Status
17 Oct 2025	Others	₹5.00 Cr	Open
08 Sep 2025	Indian Bank	₹260.00 Cr	Open
16 Jun 2025	Others	₹216.00 Cr	Open
05 Jun 2025	Others	₹50.00 Cr	Open
27 Mar 2025	Others	₹100.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Cadila Pharmaceuticals?

Cadila Pharmaceuticals has a workforce of 6144 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cadila Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadila Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cadila Pharmaceuticals

Recent Activity within the Organization

Charges

The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101173937 was registered on 17 Oct 2025. was completed.
17 Oct 2025
Charges

The activity A charge with Indian Bank amounted to Rs. 260.00 Cr with Charge ID 101154887 was registered on 08 Sep 2025. was completed.
08 Sep 2025
Charges

Progress on A charge with Others of Rs. 1,969.35 Cr registered on 15 Apr 2024 with Charge ID 100916122 was modified on 25 Jul 2025. was documented.
25 Jul 2025
Charges

The activity A charge registered on 31 Mar 2022 via Charge ID 100554686 with Others was fully satisfied on 01 Jul 2025. was completed.
01 Jul 2025
Director Appointment

Subir Kumar Das was appointed as a Additional Director was appointed as a Additional Director on 30 Jun 2025 & has been associated with this company since 7 months 22 days . was recorded as a recent event.
30 Jun 2025
Charges

The activity A charge registered on 27 Dec 2019 via Charge ID 100316138 with Others was fully satisfied on 23 Jun 2025. was completed.
23 Jun 2025

Explore recent activity and updates - View Recent Activity